<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9111376</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2201</journal-id>
<journal-id journal-id-type="nlm-ta">Curr Opin Neurobiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr. Opin. Neurobiol.</journal-id>
<journal-title-group>
<journal-title>Current opinion in neurobiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0959-4388</issn>
<issn pub-type="epub">1873-6882</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26517284</article-id>
<article-id pub-id-type="pmc">4738093</article-id>
<article-id pub-id-type="doi">10.1016/j.conb.2015.10.006</article-id>
<article-id pub-id-type="manuscript">NIHMS730684</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Modeling developmental neuropsychiatric disorders with iPSC technology: Challenges and opportunities</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Young-Pearse</surname>
<given-names>Tracy L.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morrow</surname>
<given-names>Eric M.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital and Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA</aff>
<aff id="A2"><label>b</label>Department of Molecular Biology, Cell Biology and Biochemistry (MCB), and Institute for Brain Science, Brown University, 70 Ship Street, Providence, RI 02912, USA</aff>
<aff id="A3"><label>c</label>Developmental Disorders Genetics Research Program, Emma Pendleton Bradley Hospital and Department of Psychiatry and Human Behavior, Brown University Medical School, Providence, RI 02912, USA</aff>
<author-notes>
<fn id="FN1">
<label>*</label>
<p id="P1">co-corresponding authors: <email>tyoung@rics.bwh.harvard.edu</email> and <email>Eric_Morrow@brown.edu</email></p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>22</day>
<month>10</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>24</day>
<month>10</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2017</year>
</pub-date>
<volume>36</volume>
<fpage>66</fpage>
<lpage>73</lpage>
<!--elocation-id from pubmed: 10.1016/j.conb.2015.10.006-->
<abstract>
<p id="P2">The development of cellular reprogramming methods to generate human induced pluripotent stem cells (iPSC) has led to the establishment of lines from hundreds of patients with a variety of neurologic and psychiatric diseases. One of the fundamental powers of iPSC technology lies in the competency of these cells to be directed to become any cell type in the body, thus allowing researchers to examine disease mechanisms and identify and test novel therapeutics in relevant cell types. The field has now exited the phase of “proof-of-principle” studies showing the potential of the model systems, and it has now entered an exciting new era where iPSC studies are contributing to the field’s understanding of mechanisms of disease. Here, we describe the challenges of iPSC modeling of neuropsychiatric disorders, and highlight studies where some of these challenges have been addressed to provide novel insights into disease mechanisms.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>